AU2160999A - 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives - Google Patents

17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives

Info

Publication number
AU2160999A
AU2160999A AU21609/99A AU2160999A AU2160999A AU 2160999 A AU2160999 A AU 2160999A AU 21609/99 A AU21609/99 A AU 21609/99A AU 2160999 A AU2160999 A AU 2160999A AU 2160999 A AU2160999 A AU 2160999A
Authority
AU
Australia
Prior art keywords
alkyl
17beta
arylmethyl
thio
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21609/99A
Other languages
English (en)
Inventor
Christian Heijmans
Jaap Van Der Louw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of AU2160999A publication Critical patent/AU2160999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU21609/99A 1997-12-18 1998-12-11 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives Abandoned AU2160999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97203998 1997-12-18
EP97203998 1997-12-18
PCT/EP1998/008130 WO1999032506A1 (en) 1997-12-18 1998-12-11 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES

Publications (1)

Publication Number Publication Date
AU2160999A true AU2160999A (en) 1999-07-12

Family

ID=8229080

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21609/99A Abandoned AU2160999A (en) 1997-12-18 1998-12-11 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives

Country Status (9)

Country Link
US (1) US6251887B1 (da)
EP (1) EP1042353B1 (da)
JP (1) JP2001526293A (da)
AT (1) ATE220686T1 (da)
AU (1) AU2160999A (da)
DE (1) DE69806640T2 (da)
DK (1) DK1042353T3 (da)
ES (1) ES2181321T3 (da)
WO (1) WO1999032506A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2185360T3 (es) 1998-12-11 2003-04-16 Akzo Nobel Nv Derivados de 22s-hidroxicolesta-8,14-dieno con actividad reguladora de la meiosis.
JP2002541153A (ja) * 1999-04-06 2002-12-03 アクゾ・ノベル・エヌ・ベー 経口活性アンドロゲン
WO2004044591A2 (en) * 2002-11-14 2004-05-27 Novo Nordisk A/S Use of nuclear hormone receptors to identify meiosis regulating compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
PL322106A1 (en) 1995-03-06 1998-01-05 Novo Nordisk As Meiosis stimulation
DE69630802T2 (de) 1995-06-23 2004-08-12 Novo Nordisk A/S Meiose regulierende verbindungen.
AU726016B2 (en) 1997-05-16 2000-10-26 Akzo Nobel N.V. 20-aralkyl-5alpha-pregnane derivatives
ATE215555T1 (de) 1997-06-04 2002-04-15 Akzo Nobel Nv 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose

Also Published As

Publication number Publication date
US6251887B1 (en) 2001-06-26
DK1042353T3 (da) 2002-11-04
DE69806640T2 (de) 2003-03-13
WO1999032506A1 (en) 1999-07-01
ATE220686T1 (de) 2002-08-15
ES2181321T3 (es) 2003-02-16
JP2001526293A (ja) 2001-12-18
DE69806640D1 (de) 2002-08-22
EP1042353A1 (en) 2000-10-11
EP1042353B1 (en) 2002-07-17

Similar Documents

Publication Publication Date Title
AU565898B2 (en) 1,8-naphthyridine derivatives
AU3945589A (en) Substituted 4-piperidinyl-indol-5-yl-alkyl-sulphonamide derivatives
AU6292796A (en) Radicicol derivatives
AU591640B2 (en) Quinolonecarboxylic acid derivatives
AU572978B2 (en) 1,5-benzothiazepine derivatives
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
PL337008A1 (en) Derivatives of 20-aralkyl-5alpha-pregnane
IL132799A0 (en) 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
ES8707217A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
AU2160999A (en) 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
CA2010982A1 (en) Osteogenesis promotion with use of vitamin d derivatives
AU641686B2 (en) Benzanilides
GR3031767T3 (en) Cyclopropane derivatives and antiviral agents containing the same.
AU653311B2 (en) Benzo(B)thiophen-3-yl-piperazines, as anti-psychotic agents
AU2014188A (en) Naphthothiazepine derivatives and preparation thereof
AP9400608A0 (en) "New nicotinic acid derivative".
HUT35658A (en) Process for producing 7-oxo-prostacycline derivatives of selective biological activity
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
DK1137660T3 (da) 22S-hydroxycholesta-8,14-dienderivater med meioseregulerende aktivitet
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase